A warm welcome to Bristol Myers Squibb (BMS) who are building a CAR-T facility at the Oegstgeest side of the LBSP. It is the first CAR-T cell therapy production facility for BMS outside the US.
Get familiar with their plans during the Life Sciences Café on Thursday 28 October from 16.30 onwards.